What is the cause of transient bilateral vision loss post dialysis (hemodialysis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Transient bilateral vision loss post dialysis is most likely caused by dialysis-associated reductions in blood pressure, serum potassium, and serum phosphorus, as well as changes in other electrolytes and proteins, which may lead to a "perfect storm" of stress on the brain and cardiovascular system. This is supported by the 2015 update of the KDOQI clinical practice guideline for hemodialysis adequacy 1. The exact mechanism is not fully understood, but it is thought to be related to the removal of low-molecular-weight hormones, vitamins, and other vital molecules during dialysis, as well as the exposure of the blood to a large foreign surface for several hours.

Some possible causes of transient bilateral vision loss post dialysis include:

  • Dialysis-associated reductions in blood pressure, which can lead to decreased blood flow to the brain and eyes
  • Electrolyte imbalances, such as changes in serum potassium and phosphorus levels, which can affect nerve function and muscle contractions
  • Changes in other electrolytes and proteins, which can contribute to a "perfect storm" of stress on the brain and cardiovascular system
  • Uremic toxins, which can accumulate and damage the optic nerve

To manage transient bilateral vision loss post dialysis, it is essential to:

  • Stabilize blood pressure and correct electrolyte imbalances
  • Optimize dialysis parameters, such as gradual ultrafiltration rates and sodium profiling, to minimize rapid fluid shifts
  • Evaluate patients promptly by an ophthalmologist and neurologist
  • Monitor pre-dialysis and post-dialysis weights, blood pressure readings, and electrolyte levels to prevent recurrence
  • Adjust the dialysis prescription as needed to prevent repeated episodes, as suggested by the KDOQI clinical practice guideline for hemodialysis adequacy 1.

From the Research

Causes of Transient Bilateral Vision Loss Post Dialysis

  • Transient bilateral vision loss post dialysis can be caused by hypotension-induced blindness, as reported in patients on renal dialysis who suffered severe longstanding hypotension with bilateral non-arteritic anterior ischaemic optic neuropathy 2.
  • Another possible cause is ischemic optic neuropathy, which is a risk factor associated with blood pressure decrease, a common complication of hemodialysis 3.
  • However, it is worth noting that not all cases of vision loss in dialysis patients are directly related to hypotension or ischemic optic neuropathy, as other factors such as crystal deposition in end-stage kidney disease treated with peritoneal dialysis can also lead to catastrophic retinal vascular occlusion and vision loss 4.
  • The relationship between blood pressure control and vision loss is complex, and while some studies suggest that controlling blood pressure is crucial in preventing vision loss 2, 3, others focus on the importance of blood pressure management in preventing cardiovascular and renal outcomes in patients with hypertension and type 2 diabetes 5, 6.

Related Questions

What is the next best antihypertensive medication for a 50-year-old male with uncontrolled hypertension (HTN) and a blood pressure of 150/100 mmHg, who cannot tolerate lisinopril (an angiotensin-converting enzyme inhibitor) due to a persistent cough?
What adjustments should be made to the treatment plan for a patient with uncontrolled diabetes, hypertension, and a dry cough likely induced by their current ACE inhibitor?
How are antihypertensive agents, such as Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers (CCBs), Diuretics, and Beta-Blockers (BBs), arranged in terms of potency?
What is the best course of management for an 80-year-old female with a history of hypertension and diabetes, presenting with an episode of dizziness, presyncope, and brief syncope, with hypotension, bradycardia, first-degree atrioventricular (AV) block, left bundle branch block (LBBB), and non-sustained wide complex tachycardia (WCT)?
What are the 2022 guidelines for managing medical conditions such as hypertension and diabetes?
How long do corticosteroids elevate White Blood Cell (WBC) count?
What are the interventions for Cholangitis (inflammation of the bile duct)?
What is the treatment for allergic rhinitus (allergic shiners) in a 6-year-old child?
What are the blood pressure thresholds for treatment and targets in adult Filipinos for preventing cardiovascular disease?
What is the meaning of Dextrose (D-glucose) 94 in SI units?
What are the pathophysiological differences between Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.